- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01073397
Effect of Yoga on Objective and Subjective Menopausal Hot Flashes (GLAM)
Effectiveness of Integral Yoga on Objective and Subjective Menopausal Hot Flashes
Study Overview
Detailed Description
Hot flashes and/or night sweats are the most common and troubling symptoms associated with menopause. It is estimated that 64% to 87% of women report experiencing hot flashes for an average of about 4 years. For many women, these symptoms are frequent and severe enough to become debilitating and interfere with daily activities. They often occur at night, disturbing sleep and leading to daytime irritability, fatigue and depressed mood. About 30-40% of menopausal women seek medical help for hot flashes. Relief from hot flashes has been shown to be the primary reason that women initiate hormone therapy (HT).
HT is currently the gold standard for treatment of vasomotor symptoms. A Cochrane Database systematic review showed a 75% reduction in hot flash frequency with hormone therapy compared to placebo.1 However, recent findings from the Women's Health Initiative (WHI) trial indicate that benefits of HT are outweighed by risks, such as coronary heart disease, stroke, pulmonary embolism, breast cancer, and probable dementia. The wide publicity of the WHI results has heightened women's concerns about taking HT and many women have sought alternative treatments for hot flashes. These alternatives include other pharmaceutical agents, herbal or dietary remedies, and behavioral therapies. Unfortunately, many of these agents have a high incidence of side effects or have not been shown to be effective. A recent NIH conference has called for more research on alternative treatments for hot flashes.
Behavioral interventions involving relaxation and slow deep, abdominal breathing have been found to be useful for reducing mild- to moderate-intensity hot flashes. Although the physiological mechanisms for the effectiveness of these interventions are not completely understood, there is some suggestion that they may help reduce sympathetic activity which is related to the narrowing of the thermoneutral zone. It is currently thought that hot flashes are linked to a disruption in thermoregulation and that elevated levels of brain norepinephrine may be the primary mechanism for altered thermoregulation. Breathing techniques form the most integral core of any yoga practice which involves the combination of physical postures (asanas), breathing (pranayama), and deep relaxation (savasana). Despite suggestions that yoga may be beneficial for the relief of hot flashes, these potential benefits have not been well-studied.
To date, treatment efficacy for hot flashes has been limited to self-reported, subjective symptoms. While subjective hot flashes are important from a woman's perspective in her decision-making with respect to treatment, research has shown that they can be influenced by mood and reporting biases. Objective measures are not subject to these biases and have the advantage of providing insight as to whether an intervention has a physiological effect. However, until recently, reliable objective measures that could be used in an ambulatory setting were not available. NCCAM has recently funded the development of new technologies to monitor objective hot flashes in an ambulatory setting, as measured by skin conductance. This technology greatly enhances our ability to fully evaluate the impact of treatment on both subjective and objective hot flashes.
The primary goal of this R21 pilot grant is to obtain preliminary data on the efficacy of Integral Yoga for reducing self-reported menopausal hot flashes. Secondary aims are to determine the impact of yoga on objective hot flashes and other outcomes and study feasibility. Our primary hypothesis will be a greater reduction in subjective hot flash frequency and severity in the yoga group than in two control groups. Secondary outcomes will include a greater reduction in objective hot flash frequency; a greater decrease in hot flash interference; and greater improvement in sleep, other symptoms, mood, perceived stress, and overall quality of life in the yoga group.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest University Health Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- At least 2 months since last menses
- Age 45-58 years
- Moderate to severe vasomotor symptoms for at least 4 weeks (at least 4/day on average)
- Self-reported general good health
- Adequate English to understand informed consent form, questionnaires, and converse with study staff
- Agree not to use pharmaceutical agents for treating hot flashes during the study
Exclusion Criteria:
- Hormone therapy use within 12 weeks prior to study screening, including systemic estrogen, progestin or androgen therapy
- Selective estrogen receptor modulator (Evista® and Novaldex®) or aromatase inhibitor use within 6 months
- Cancer at any time
- Untreated thyroid disease
- Initiation of herbal or nutritional supplements for hot flashes within the past 4 weeks
- Significant psychiatric disorder, including regular use of antidepressants or anxiolytics
- Regular use of clonidine or Bellergal® within the past 12 weeks
- Any past use of yoga for hot flashes
- Yoga or Acupuncture for any reason within the past 3 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Behavioral
Weekly Integral Yoga sessions lasting 90 minutes for 10 weeks with home practice.
|
Integral Yoga class (90 minutes per class), Once weekly for 10 weeks
|
|
ACTIVE_COMPARATOR: Health and Wellness Classes
Weekly classes on health and wellness lasting 90 minutes for 10 weeks, with additional home practice
|
Integral Yoga class (90 minutes per class), Once weekly for 10 weeks
|
|
NO_INTERVENTION: Waitlist
This group receives usual care for 10 weeks and is then randomized to one of the study arms.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective Hot Flashes
Time Frame: Weekly
|
Subjective hot flashes measured by daily diaries
|
Weekly
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Objective hot flashes
Time Frame: 3 days
|
Objective hot flashes measured by skin conductance.
|
3 days
|
|
Hot flash interference
Time Frame: 1 week
|
This measure assesses the impact of hot flashes on daily activities and quality of life.
|
1 week
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Nancy E Avis, PhD, Wake Forest University Health Sciences
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00009138
- 1R21AT004234-01A2 (NIH)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vasomotor Symptoms
-
ApexCPG LLCRecruiting
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedVasomotor SymptomsMexico
-
Hansoh BioMedical R&D CompanyRecruiting
-
Northwestern UniversityCompletedVasomotor SymptomsUnited States
-
BayerCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
BayerCompleted
-
Tanabe Pharma CorporationCompleted
-
Duramed ResearchCompletedNocturnal Vasomotor SymptomsUnited States
-
Tanabe Pharma America, Inc.CompletedVasomotor Symptoms (VMS)United States
Clinical Trials on Yoga
-
Universität Duisburg-EssenCompleted
-
Ataturk UniversityKTO Karatay UniversityRecruiting
-
University of Texas at AustinCompleted
-
Adiyaman University Research HospitalCompletedDepression | Stress | Anxiety | Psychological ResilienceTurkey
-
NMP Medical Research InstituteYog-Kulam; Department of Zoology, University of Rajasthan, IndiaCompleted
-
NMP Medical Research InstituteWarwick Research Services; Yog-KulamCompleted
-
Northwestern UniversityCompleted
-
University of MinnesotaCompleted
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedDepression | Pain | Breast Cancer | FatigueUnited States
-
Saglik Bilimleri UniversitesiThe Scientific and Technological Research Council of TurkeyCompletedStress | Anxiety | Telerehabilitation | Yoga | University StudentsTurkey